Saved in:
| Main Authors: | Payel Sen, Lili Wang, Laura d'Ambrosio, Susanne Bierschenk, Jules Hamers, Irem Ornek, Theresa Sittig, Hengliang Zhang, Junqing Zhang, Daphne Merkus |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.70521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Comment on: Malnutrition in heart failure with preserved ejection fraction
by: Conrad May
Published: (2024)
by: Conrad May
Published: (2024)
Reply to: Comment on: Malnutrition in heart failure with preserved ejection fraction
by: Ellen Brinza, et al.
Published: (2024)
by: Ellen Brinza, et al.
Published: (2024)
Treatment of heart failure with preserved ejection fraction. A systematic review
by: WALTER GABRIEL CHAVES-SANTIAGO
Published: (2022)
by: WALTER GABRIEL CHAVES-SANTIAGO
Published: (2022)
The keto cure? Exploring ketogenic diet in heart failure with preserved ejection fraction
by: Bagus Aditya Ansharullah, et al.
Published: (2025)
by: Bagus Aditya Ansharullah, et al.
Published: (2025)
Exercise‐induced arterial hypoxaemia in patients with heart failure with preserved ejection fraction
by: Michael G. Leahy, et al.
Published: (2025)
by: Michael G. Leahy, et al.
Published: (2025)
Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity
by: Ayesha Rehman, et al.
Published: (2024)
by: Ayesha Rehman, et al.
Published: (2024)
Vascular remodelling in a mouse model of heart failure with preserved ejection fraction
by: Fernanda Sanhueza‐Olivares, et al.
Published: (2025)
by: Fernanda Sanhueza‐Olivares, et al.
Published: (2025)
Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Lessons From Large Animal Models
by: Oana Sorop, et al.
Published: (2025)
by: Oana Sorop, et al.
Published: (2025)
Strain‐based characterization of atrioventricular and left atrial remodelling in rat models of heart failure with preserved ejection fraction
by: Qingfeng Zhang, et al.
Published: (2026)
by: Qingfeng Zhang, et al.
Published: (2026)
Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes
by: Takefumi Kishimori, et al.
Published: (2026)
by: Takefumi Kishimori, et al.
Published: (2026)
ALPK2 prevents cardiac diastolic dysfunction in heart failure with preserved ejection fraction
by: Tatsuya Yoshida, et al.
Published: (2024)
by: Tatsuya Yoshida, et al.
Published: (2024)
ExploitWP2Docker: a Platform for Automating the Generation of Vulnerable WordPress Environments for Cyber Ranges
by: Caturano, Francesco, et al.
Published: (2022)
by: Caturano, Francesco, et al.
Published: (2022)
Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study
by: Adhish Agarwal, et al.
Published: (2024)
by: Adhish Agarwal, et al.
Published: (2024)
Adipose‐derived small extracellular vesicles exacerbate microvascular dysfunction in heart failure with preserved ejection fraction via mmu‐miR‐582‐3p‐mediated Rap1b suppression
by: Lu Chen, et al.
Published: (2026)
by: Lu Chen, et al.
Published: (2026)
Improving therapeutic outcomes in heart failure with reduced nonvalvular ejection fraction: A clinical study of heart failure education intervention
by: Xueli Tian, et al.
Published: (2024)
by: Xueli Tian, et al.
Published: (2024)
Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center
by: Daniel Bradley
Published: (2019)
by: Daniel Bradley
Published: (2019)
Body composition in patients with obesity‐related heart failure with preserved ejection fraction: A comparison study
by: Hannah Salmons, et al.
Published: (2025)
by: Hannah Salmons, et al.
Published: (2025)
A new sympathetic understanding of exercise blood flow regulation in heart failure with preserved ejection fraction
by: Giorgio Manferdelli, et al.
Published: (2024)
by: Giorgio Manferdelli, et al.
Published: (2024)
Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
by: Iskandar Idris
Published: (2024)
by: Iskandar Idris
Published: (2024)
Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction
by: Francesca Lockwood, et al.
Published: (2025)
by: Francesca Lockwood, et al.
Published: (2025)
Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis
by: Szu‐Han Chen, et al.
Published: (2026)
by: Szu‐Han Chen, et al.
Published: (2026)
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
by: Zhongwen Qi, et al.
Published: (2025)
by: Zhongwen Qi, et al.
Published: (2025)
Phenotyping of acute heart failure with preserved ejection fraction: real‐world outcomes in a cohort of older patients
by: Maria Livia Burzo, et al.
Published: (2026)
by: Maria Livia Burzo, et al.
Published: (2026)
α‐Adrenergic regulation of skeletal muscle blood flow during exercise in patients with heart failure with preserved ejection fraction
by: Jeremy K. Alpenglow, et al.
Published: (2024)
by: Jeremy K. Alpenglow, et al.
Published: (2024)
Breathless but unchanged: Exercise‐induced arterial hypoxaemia shows limited impact in patients with heart failure with preserved ejection fraction
by: Jeff Jiefu Liu, et al.
Published: (2025)
by: Jeff Jiefu Liu, et al.
Published: (2025)
Distinguishing pathophysiological features of heart failure with reduced and preserved ejection fraction: A comparative analysis of two mouse models
by: Abraham Méndez‐Fernández, et al.
Published: (2024)
by: Abraham Méndez‐Fernández, et al.
Published: (2024)
HBI‐8000 improves heart failure with preserved ejection fraction via the TGF‐β1/MAPK signalling pathway
by: Jing Tian, et al.
Published: (2024)
by: Jing Tian, et al.
Published: (2024)
Hypertension and obesity independently drive hypertrophy and alter mitochondrial metabolism in a mouse model of heart failure with preserved ejection fraction
by: Benjamin Werbner, et al.
Published: (2024)
by: Benjamin Werbner, et al.
Published: (2024)
Is sinus rhythm maintenance after repeat catheter ablation effective in patients with atrial fibrillation and heart failure with preserved ejection fraction?
by: Yasuyuki Egami, et al.
Published: (2024)
by: Yasuyuki Egami, et al.
Published: (2024)
Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING‐HF trial
by: Patricia Palau, et al.
Published: (2024)
by: Patricia Palau, et al.
Published: (2024)
The value of the HFA‐PEFF and H2FPEF scores in determining the phenotypes and comorbidity burden in heart failure with preserved ejection fraction
by: Selda Murat, et al.
Published: (2025)
by: Selda Murat, et al.
Published: (2025)
PINK1 modulates Prdx2 to reduce lipotoxicity‐induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction
by: Hao Zhang, et al.
Published: (2025)
by: Hao Zhang, et al.
Published: (2025)
Epidemiological and clinical characterization of patients hospitalized for decompensated heart failure with reduced ejection fraction
by: Laura Catalina Arcos-Medina
Published: (2020)
by: Laura Catalina Arcos-Medina
Published: (2020)
Practical considerations for the use of vericiguat in older patients with heart failure and reduced ejection fraction
by: Francesco Castelletti, et al.
Published: (2026)
by: Francesco Castelletti, et al.
Published: (2026)
Förderung von heterogenen Zielgruppen im Übergang Schule – Beruf
by: Sittig, Melanie
Published: (2025)
by: Sittig, Melanie
Published: (2025)
Oyun ve Gerçeklik
by: Örnek, Hakan
Published: (2024)
by: Örnek, Hakan
Published: (2024)
Association Between the Red Cell Distribution Width‐to‐Albumin Ratio and Pediatric Community‐Acquired Pneumonia
by: Zühal Örnek
Published: (2026)
by: Zühal Örnek
Published: (2026)
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study
by: Xiao‐Dong Zhou, et al.
Published: (2024)
by: Xiao‐Dong Zhou, et al.
Published: (2024)
Current treatment for heart failure with reduced ejection fraction. A systematic review of the new therapies
by: JAIRO ALFONSO GÁNDARA-RICARDO
Published: (2021)
by: JAIRO ALFONSO GÁNDARA-RICARDO
Published: (2021)
Renal function trajectories in 'De Novo' heart failure with reduced ejection fraction: impact on outcomes
by: Otero-García, O., et al.
Published: (2026)
by: Otero-García, O., et al.
Published: (2026)
Similar Items
-
Comment on: Malnutrition in heart failure with preserved ejection fraction
by: Conrad May
Published: (2024) -
Reply to: Comment on: Malnutrition in heart failure with preserved ejection fraction
by: Ellen Brinza, et al.
Published: (2024) -
Treatment of heart failure with preserved ejection fraction. A systematic review
by: WALTER GABRIEL CHAVES-SANTIAGO
Published: (2022) -
The keto cure? Exploring ketogenic diet in heart failure with preserved ejection fraction
by: Bagus Aditya Ansharullah, et al.
Published: (2025) -
Exercise‐induced arterial hypoxaemia in patients with heart failure with preserved ejection fraction
by: Michael G. Leahy, et al.
Published: (2025)